106 related articles for article (PubMed ID: 33662364)
1. The C-terminus of Brucella abortus MviN induces humoral and cell mediated immune responses in BALB/c mice that protects against the virulent Brucella 544 challenge.
Senevirathne A; Hewawaduge C; Kim S; Lee JH
J Immunol Methods; 2021 Jun; 493():113005. PubMed ID: 33662364
[TBL] [Abstract][Full Text] [Related]
2. Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge.
Senevirathne A; Hewawaduge C; Lee JH
Vet Res; 2020 Jan; 51(1):6. PubMed ID: 31973749
[TBL] [Abstract][Full Text] [Related]
3. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
[TBL] [Abstract][Full Text] [Related]
4. Attenuated Salmonella secreting Brucella protective antigens confer dual-faceted protection against brucellosis and salmonellosis in a mouse model.
Senevirathne A; Hewawaduge C; Lee JH
Vet Immunol Immunopathol; 2019 Mar; 209():31-36. PubMed ID: 30885303
[TBL] [Abstract][Full Text] [Related]
5. Substantial Protective Immunity Conferred by a Combination of
Arayan LT; Huy TXN; Reyes AWB; Hop HT; Son VH; Min W; Lee HJ; Kim S
J Microbiol Biotechnol; 2019 Feb; 29(2):330-338. PubMed ID: 30609879
[TBL] [Abstract][Full Text] [Related]
6. Protective and therapeutic efficacy study of divalent fusion protein rL7/L12-Omp25 against B. abortus 544 in presence of IFNγ.
Paul S; Peddayelachagiri BV; Nagaraj S; Konduru B; Batra HV
Appl Microbiol Biotechnol; 2018 Oct; 102(20):8895-8907. PubMed ID: 30136204
[TBL] [Abstract][Full Text] [Related]
7. Recombinant outer membrane protein 25c from Brucella abortus induces Th1 and Th2 mediated protection against Brucella abortus infection in mouse model.
Paul S; Peddayelachagiri BV; Nagaraj S; Kingston JJ; Batra HV
Mol Immunol; 2018 Jul; 99():9-18. PubMed ID: 29649688
[TBL] [Abstract][Full Text] [Related]
8. Immunization of Mice with Recombinant Brucella abortus Organic Hydroperoxide Resistance (Ohr) Protein Protects Against a Virulent Brucella abortus 544 Infection.
Hop HT; Reyes AW; Simborio HL; Arayan LT; Min WG; Lee HJ; Lee JJ; Chang HH; Kim S
J Microbiol Biotechnol; 2016 Jan; 26(1):190-6. PubMed ID: 26464379
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and protective effect of recombinant Brucella abortus Ndk (rNdk) against a virulent strain B. abortus 544 infection in BALB/c mice.
Hop HT; Simborio HL; Reyes AW; Arayan LT; Min W; Lee HJ; Kim DH; Chang HH; Kim S
FEMS Microbiol Lett; 2015 Feb; 362(4):. PubMed ID: 25724777
[TBL] [Abstract][Full Text] [Related]
10. Th2-related immune responses by the Brucella abortus cellular antigens, malate dehydrogenase, elongation factor, and arginase.
Im YB; Shim S; Park WB; Kim S; Yoo HS
Microb Pathog; 2017 Sep; 110():7-13. PubMed ID: 28629726
[TBL] [Abstract][Full Text] [Related]
11. Immunogencity of HSA-L7/L12 (Brucella abortus ribosomal protein) in an animal model.
Pakzad I; Rezaee A; Rasaee MJ; Tabbaraee B; Delpisheh A
Iran J Immunol; 2009 Mar; 6(1):12-21. PubMed ID: 19293473
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective response induced by recombinant Brucella abortus proteins Adk, SecB and combination of these two recombinant proteins against a virulent strain B. abortus 544 infection in BALB/c mice.
Huy TXN; Bernardo Reyes AW; Vu SH; Arayan LT; Hop HT; Min W; Lee HJ; Lee JH; Kim S
Microb Pathog; 2020 Jun; 143():104137. PubMed ID: 32169487
[TBL] [Abstract][Full Text] [Related]
13. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
[TBL] [Abstract][Full Text] [Related]
14. A combined subunit vaccine comprising BP26, Omp25 and L7/L12 against brucellosis.
Gupta S; Singh D; Gupta M; Bhatnagar R
Pathog Dis; 2019 Nov; 77(8):. PubMed ID: 31971564
[TBL] [Abstract][Full Text] [Related]
15. Cell mediated immune response after challenge in Omp25 liposome immunized mice contributes to protection against virulent Brucella abortus 544.
Goel D; Rajendran V; Ghosh PC; Bhatnagar R
Vaccine; 2013 Feb; 31(8):1231-7. PubMed ID: 23273966
[TBL] [Abstract][Full Text] [Related]
16. Intradermal immunization with outer membrane protein 25 protects Balb/c mice from virulent B. abortus 544.
Goel D; Bhatnagar R
Mol Immunol; 2012 Jun; 51(2):159-68. PubMed ID: 22464098
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with recombinant flagellar proteins FlgJ and FliN induce protection against Brucella abortus 544 infection in BALB/c mice.
Li X; Xu J; Xie Y; Qiu Y; Fu S; Yuan X; Ke Y; Yu S; Du X; Cui M; Chen Y; Wang T; Wang Z; Yu Y; Huang K; Huang L; Peng G; Chen Z; Wang Y
Vet Microbiol; 2012 Dec; 161(1-2):137-44. PubMed ID: 22854331
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Brucella abortus proteins that induce proliferation and gamma-interferon secretion by CD4+ T cells from Brucella-vaccinated mice and delayed-type hypersensitivity in sensitized guinea pigs.
Oliveira SC; Harms JS; Banai M; Splitter GA
Cell Immunol; 1996 Sep; 172(2):262-8. PubMed ID: 8964089
[TBL] [Abstract][Full Text] [Related]
19. Intraspleen delivery of a DNA vaccine coding for superoxide dismutase (SOD) of Brucella abortus induces SOD-specific CD4+ and CD8+ T cells.
Muñoz-Montesino C; Andrews E; Rivers R; González-Smith A; Moraga-Cid G; Folch H; Céspedes S; Oñate AA
Infect Immun; 2004 Apr; 72(4):2081-7. PubMed ID: 15039330
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice.
Sislema-Egas F; Céspedes S; Fernández P; Retamal-Díaz A; Sáez D; Oñate A
Vaccine; 2012 Nov; 30(50):7286-91. PubMed ID: 23026687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
